EDAP TMS Says FDA Grants Breakthrough Designation To Focal One For Rectal Endometriosis

EDAP TMS SA (EDAP) announced Monday that its Focal One platform has been granted Breakthrough Device designation by the US Food and Drug Administration (FDA) for the treatment of deep infiltrating endometriosis (DIE). Focal One HIFU is a non-invasive, robotic ablative procedure using a high-intensity ultrasound probe to deliver tissue devitalization through use of acoustic...

Read More

Asian Shares Mixed As China Holds Rates

Asian stocks traded mixed on Tuesday as the Peoples Bank of China kept its benchmark loan prime rate unchanged following a surprise cut in July. Investors also assessed minutes from the Reserve Bank of Australias August meeting and looked ahead to the release of FOMC meeting minutes and Fed Chair Jerome Powells Jackson Hole Speech...

Read More

China GDP Data Due On Friday

China is scheduled to release a raft of data on Friday, headlining a busy day for Asia-Pacific economic activity. On tap are Q3 numbers for gross domestic product, as well as September figures for industrial production, retail sales, fixed asset investment and unemployment. GDP is expected to add 0.5 percent on quarter and 4.6 percent...

Read More